TMCnet News
Merz Neurosciences to Present XEOMIN® (IncobotulinumtoxinA) Data at the 21st International Congress of Parkinson's Disease and Movement DisordersMerz Neurosciences, a division of Merz North America, announced today that it will present a late breaking poster and four additional poster presentations at the 21st International Congress of Parkinson's Disease and Movement Disorders (MDS) in Vancouver, BC taking place from June 4-8, 2017. "The breadth of data to be presented is encouraging and provides valuable information to the scientific and medical communities. The results will deepen understanding of the complexities of treating, and the challenges of living with, neurological disorders," said Bob Rhatigan, President and CEO of Merz North America. "We are committed to ongoing research that can ultimately help patients by providing new treatment options to address the unique needs of patients suffering from neurologic, movement and spasticity disorders." On Wednesday, June 7, the following Late-Breaking & Study Group Abstract Poster will be presented in Ballroom D of the Vancouver Convention Centre - WEST from 1:15 p.m. until 2:45 p.m. (PT) and will be displayed for the entire duration of the Scientific Program (Monday, June 5 - Thursday, June 8).
The following four posters will be presented in Exhibit Hall C of the Vancouver Convention Centre - WEST from 1:15 p.m. until 2:45 p.m. (PT) and will be available for viewing from 9:00 a.m. until 5:00 p.m. on the day of presentation only.
Merz is also pleased to be supporting the following Educational Sessions:
For more information, please see XEOMIN full Prescribing Information and Medication Guide. About XEOMIN® (incobotulinumtoxinA) XEOMIN® (incobotulinumtoxinA) is a prescription medicine that is injected into muscles and used to treat increased muscle stiffness in the arm of adults with upper limb spasticity, the abnormal head position and neck pain that happens with cervical dystonia (CD) in adults, and to treat abnormal spasm of the eyelids (blepharospasm) in adults who have had prior treatment with onabotulinumtoxinA (Botox®). To learn more about Merz Neurosciences and their U.S. product portfolio, please visit www.merzusa.com/neurosciences. XEOMIN® IMPORTANT CONSUMER SAFETY INFORMATION Read the Medication Guide before you start receiving XEOMIN® (Zeo-min) and each time XEOMIN® is given to you as there may be new inormation. The risk information provided here is not comprehensive. To learn more:
Uses XEOMIN® is a prescription medicine that is injected into muscles and used to treat:
It is not known whether XEOMIN® is safe or effective in children. Warnings XEOMIN® may cause serious side effects that can be life threatening. Call your doctor or get medical help right away if you have any of these problems anytime (hours to weeks) after treatment with XEOMIN®:
These problems could make it unsafe for you to drive a car or do other dangerous activities. Do not take XEOMIN® if you: are allergic to XEOMIN® or any of the ingredients in XEOMIN® (see the end of this Guide for a list of ingredients in XEOMIN®), had an allergic reaction to any other botulinum toxin product such as rimabotulinumtoxinB (Myobloc®), onabotulinumtoxinA (Botox®, Botox® Cosmetic), or abobotulinumtoxinA (Dysport®) or have a skin infection at the planned injection site. Ask a doctor before use if you
Tell your doctor about all of your medical conditions and all of the medicines you take, including: prescription and over-the-counter medicines, vitamins and herbal supplements. Using XEOMIN® with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received XEOMIN in the past. Especially tell your doctor if you:
Ask your doctor if you are not sure if your medicine is one that is listed above. Possible Side Effects XEOMIN® can cause serious side effects that can be life threatening. See "Warnings." The most common side effects of XEOMIN® include:
XEOMIN® may cause other serious side effects including allergic reactions. Symptoms of an allergic reaction to XEOMIN® may include: itching, rash, redness, swelling, wheezing, asthma symptoms, dizziness or feeling faint. Tell your doctor or get medical help right away if you have wheezing or asthma symptoms, or if you get dizzy or faint. These are not all the possible side effects of XEOMIN®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Directions
General information about the safe and effective use of XEOMIN Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use XEOMIN for a condition for which it was not prescribed. Do not give XEOMIN to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or doctor for information about XEOMIN that is written for health professionals. Active Ingredient: incobotulinumtoxinA Inactive Ingredients: human albumin and sucrose Copyright © 2016 Merz North America, Inc. All rights reserved. MERZ, the MERZ logo, and XEOMIN are registered trademarks of Merz Pharma GmbH & Co. KgaA. Botox, Dysport and Myobloc are registered trademarks of their respective owners. For more information, please see XEOMIN full Prescribing Information and Medication Guide. About Merz Neurosciences Merz Neurosciences is a division of Merz North America and is deeply committed to offering novel therapeutic options that address the largely unmet medical needs that exist within the area of neuroscience. Merz Neurosciences is an important contributor to the U.S. neurosciences space and offers a portfolio that includes the neurotoxin Xeomin® (incobotulinumtoxinA), the anticholinergic Cuvposa® (glycopyrrolate) Oral Solution and the Prolaryn® injectable implant family of products. To learn more about Merz Neurosciences and their U.S. product portfolio, please visit www.merzusa.com/neurosciences. About Merz North America Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the United States and Canada. Merz products are distributed through two divisions, Aesthetics and Neurosciences, and are developed with the goal of improving patients' health and quality of life by delivering therapies that bring about real progress. Merz North America is a privately-held company based in Raleigh, North Carolina. To learn more about Merz North America, please visit www.merzusa.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170602005411/en/ |